Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 18Terminated 7Unknown 3Withdrawn 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

cyclopia sequence 1Lymphoma, B-Cell 1Lung Neoplasms 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Modafinil × Clear all
NCT01048983 2015-03-05

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Thoracic

cyclopia sequence, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01044004 2013-07-23

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Washington University School of Medicine

Phase NA Withdrawn
Lymphoid

Fatigue, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡